von Willebrand Disease
Information
- Disease name
- von Willebrand Disease
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT04953884 | Active, not recruiting | Phase 3 | Efficacy, PK, Immunogenicity and Safety of Wilate in Severe Von Willebrand Disease VWD) Patients <6 Years of Age | July 28, 2021 | December 2024 |
| NCT00555555 | Active, not recruiting | Phase 4 | Efficacy of Alphanate FVIII/VWF Concentrate in Type 3 Von Willebrand Patients | September 2007 | March 2029 |
| NCT00168090 | Completed | Phase 4 | Study of Safety and Efficacy of Antihemophilic Factor/Von Willebrand Factor Complex in Surgical Subjects With Von Willebrand Disease (vWD) | October 2001 | May 2006 |
| NCT01224808 | Completed | Phase 3 | Extension Study of Biostate in Subjects With Von Willebrand Disease | October 2010 | March 2014 |
| NCT00151125 | Completed | Phase 2 | Phase II Study of IL-11 (Neumega) in Von Willebrand Disease | July 2004 | December 2007 |
| NCT00994929 | Completed | Phase 2 | Efficacy and Safety of IL-11 in DDAVP Unresponsive | January 2010 | April 2012 |
| NCT01213446 | Completed | Phase 3 | Study of Biostate® in Children With Von Willebrand Disease | August 2010 | August 2013 |
| NCT00111215 | Completed | N/A | Treatment and Management of Women With Bleeding Disorders | January 2001 | September 2006 |
| NCT01410227 | Completed | Phase 3 | Pharmacokinetics, Safety and Efficacy of Recombinant Von Willebrand Factor (rVWF) in the Treatment of Bleeding Episodes in Von Willebrand Disease (VWD) | November 1, 2011 | February 1, 2014 |
| NCT01589848 | Completed | Study on Von Willebrand Disease and Hemophilia in Cuenca, Ecuador | March 2013 | June 2013 | |
| NCT01602419 | Completed | Surveillance of Safety and Efficacy of Wilate in Patients With Von Willebrand Disease | October 2012 | April 2018 | |
| NCT01949220 | Completed | Willebrand International Non-interventional Global Surveillance | March 2014 | December 2017 | |
| NCT02246881 | Completed | Phase 3 | A Study to Compare the Pharmacokinetics and Safety of Current Factor VIII Concentrate and Optivate® in Haemophilia A. | October 2001 | |
| NCT02283268 | Completed | Phase 3 | Recombinant Von Willebrand Factor in Subjects With Severe Von Willebrand Disease Undergoing Surgery | April 1, 2015 | July 6, 2016 |
| NCT02552576 | Completed | Phase 4 | Study of Voncento® in Subjects With Von Willebrand Disease | October 5, 2015 | February 15, 2018 |
| NCT02792205 | Completed | Performance Evaluation of Von Willebrand:Collagen-Binding Assays to Diagnose Von Willebrand Factor Deficiency in Patients With Increased Risk of Bleeding | February 22, 2017 | June 30, 2021 | |
| NCT02973087 | Completed | Phase 3 | rVWF IN PROPHYLAXIS | November 16, 2017 | July 6, 2020 |
| NCT04657887 | Completed | Registry of Patients With Von WilLEbrand Disease Treated With Voncento® | November 23, 2015 | December 31, 2023 | |
| NCT00510042 | Completed | National Study of Moderate and Severe Von Willebrand Disease in the Netherlands | July 2007 | September 2009 | |
| NCT00524342 | Completed | Phase 2 | IL-11 in Women With Von Willebrand Disease and Refractory Menorrhagia | January 2008 | December 2010 |
| NCT00557908 | Completed | The Von Willebrand Disease (VWD) International Prophylaxis Study | June 2007 | February 2013 | |
| NCT00701545 | Completed | A Canadian Study to Assess the Safety of Humate-P® Ivr (Infusion Volume Reduced) | February 2008 | April 2009 | |
| NCT00805051 | Completed | Acquired Von Willebrand Syndrome in Severe Aortic Stenosis | October 2008 | August 2010 | |
| NCT00816660 | Completed | Phase 1 | Pharmacokinetic, Safety and Tolerability Study of Recombinant Von Willebrand Factor / Recombinant Factor VIII Complex in Type 3 Von Willebrand Disease | December 1, 2008 | August 31, 2010 |
| NCT00941616 | Completed | Phase 2/Phase 3 | Study of a pd VWF/FVIII Concentrate, Biostate®, in Subjects With Von Willebrand Disease | June 2009 | February 2012 |
| NCT02472665 | Recruiting | Phase 4 | Efficacy and Safety of Fanhdi®, a High-purity Von Willebrand Containing FVIII Concentrate, in Pediatric Patients With Von Willebrand Disease | December 2013 | December 2024 |
| NCT02932618 | Recruiting | Phase 3 | A Study of Recombinant Von Willebrand Factor (rVWF) With or Without ADVATE in Children With Severe Von Willebrand Disease (VWD) | December 18, 2017 | January 1, 2025 |
| NCT00404300 | Terminated | Phase 3 | Optivate in People With Von Willebrand Disease Undergoing Surgery | February 2007 | September 2008 |
| NCT00524225 | Terminated | Phase 2 | IL-11 in Adults With Von Willebrand Disease Undergoing Surgery | February 2008 | June 2012 |
| NCT00178542 | Terminated | Change in Thrombin Generation Potential and Thromboelastography During the Menstrual Cycle | September 2005 | April 2013 | |
| NCT00387192 | Terminated | Phase 3 | A Study With OPTIVATE® in People With Von Willebrand Disease | November 2006 | September 2008 |
| NCT02869074 | Unknown status | Molecular and Clinical Profile of Von Willebrand Disease in Spain | October 3, 2017 | August 31, 2021 | |
| NCT01261936 | Unknown status | Evaluation of Menses in Congenital Bleeding Disorders | February 2010 | December 2011 | |
| NCT03521583 | Unknown status | Von Willebrand Disease in the Netherlands | July 28, 2019 | January 2022 | |
| NCT04279717 | Unknown status | Latin-American Von Willebrand Disease Registry | February 2020 | December 2022 | |
| NCT00630448 | Withdrawn | Collection of Blood in Normal Subjects and Subjects With Von Willebrand Disease (VWD) | November 2008 | July 2011 | |
| NCT00694785 | Withdrawn | Phase 2 | A Study of the Pharmacokinetics, Pharmacodynamics, and Safety of ARC1779 Injection in Patients With Von Willebrand Disease Type 2B | October 2008 | |
| NCT01651468 | Withdrawn | N/A | The Effect of the Nutraceutical "Hemofix" on the Coagulation System | September 2016 | December 2023 |
- OrphaNumber from OrphaNet (Orphanet)
- 903
- ICD10 preferred id (Insert disease from ICD10)
- D0003246
- ICD10 class code (Insert disease from ICD10)
- D68.0